Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.8B |
| 2 |
Alibaba
BABA
|
+$1.34B |
| 3 |
Tesla
TSLA
|
+$791M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$586M |
| 5 |
Itaú Unibanco
ITUB
|
+$398M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Apple
AAPL
|
+$2.09B |
| 3 |
Visa
V
|
+$1.65B |
| 4 |
Amazon
AMZN
|
+$1.44B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.26B |
Sector Composition
| 1 | Technology | 17.72% |
| 2 | Consumer Discretionary | 11.99% |
| 3 | Healthcare | 9.74% |
| 4 | Financials | 8.93% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1851
La-Z-Boy
LZB
$1.39B
| $11.2M | ﹤0.01% |
354,959
+155,527
| +78% | +$4.92M |
|
|
CELL
1852
DELISTED
PhenomeX Inc. Common Stock
CELL
| $11.2M | ﹤0.01% |
+147,029
| New | +$11.2M |
|
|
VSTO
1853
DELISTED
Vista Outdoor Inc.
VSTO
| $11.2M | ﹤0.01% |
556,119
+369,066
| +197% | +$7.45M |
|
|
RDUS
1854
DELISTED
Radius Health, Inc.
RDUS
| $11.2M | ﹤0.01% |
988,276
+4,697
| +0.5% | +$53.3K |
|
1855
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$342M
| $11.2M | ﹤0.01% |
130,021
+61,432
| +90% | +$5.29M |
|
1856
AerCap
AER
$21.6B
| $11.2M | ﹤0.01% |
443,582
-122,650
| -22% | -$3.09M |
|
1857
Strategic Education
STRA
$1.96B
| $11.1M | ﹤0.01% |
121,662
-67,910
| -36% | -$6.21M |
|
1858
Veracyte
VCYT
$2.5B
| $11.1M | ﹤0.01% |
342,017
+51,489
| +18% | +$1.67M |
|
1859
Mersana Therapeutics
MRSN
$35.7M
| $11.1M | ﹤0.01% |
23,847
+6,553
| +38% | +$3.05M |
|
1860
Fabrinet
FN
$12.8B
| $11.1M | ﹤0.01% |
176,080
-221,987
| -56% | -$14M |
|
|
SYKE
1861
DELISTED
SYKES Enterprises Inc
SYKE
| $11.1M | ﹤0.01% |
324,118
+163,498
| +102% | +$5.59M |
|
1862
Extreme Networks
EXTR
$2.94B
| $11.1M | ﹤0.01% |
2,757,185
-363,385
| -12% | -$1.46M |
|
|
TWOU
1863
DELISTED
2U, Inc.
TWOU
| $11.1M | ﹤0.01% |
10,906
-2,469
| -18% | -$2.51M |
|
|
CHCT
1864
Community Healthcare Trust
CHCT
$432M
| $11.1M | ﹤0.01% |
236,856
+16,321
| +7% | +$763K |
|
1865
Diodes
DIOD
$2.52B
| $11.1M | ﹤0.01% |
196,063
-22,241
| -10% | -$1.26M |
|
1866
Natural Resource Partners
NRP
$1.34B
| $11.1M | ﹤0.01% |
928,447
-940
| -0.1% | -$11.2K |
|
|
BMY.RT
1867
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $11M | ﹤0.01% |
4,909,725
-305,597
| -6% | -$688K |
|
|
GTHX
1868
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $11M | ﹤0.01% |
956,001
+704,486
| +280% | +$8.14M |
|
1869
Liberty Broadband Class A
LBRDA
$8.8B
| $11M | ﹤0.01% |
77,599
-18,102
| -19% | -$2.57M |
|
1870
Dorman Products
DORM
$4.79B
| $11M | ﹤0.01% |
121,743
-23,957
| -16% | -$2.17M |
|
|
FTOCU
1871
DELISTED
FTAC Olympus Acquisition Corp. Unit
FTOCU
| $11M | ﹤0.01% |
+1,099,635
| New | +$11M |
|
1872
CommScope
COMM
$3.61B
| $11M | ﹤0.01% |
1,220,799
-38,106
| -3% | -$343K |
|
1873
iShares 3-7 Year Treasury Bond ETF
IEI
$16.9B
| $11M | ﹤0.01% |
82,157
-136,424
| -62% | -$18.2M |
|
1874
Criteo
CRTO
$1.17B
| $10.9M | ﹤0.01% |
897,735
+828,669
| +1,200% | +$10.1M |
|
1875
PagerDuty
PD
$1.48B
| $10.9M | ﹤0.01% |
403,394
+344,690
| +587% | +$9.34M |
|